By: Steve Soman, Co-Editor-in-Chief

As Americans, we often admire the courage and sacrifice of the men and women serving our country in the armed forces.  As members of the pharmacy community, we admire the professionalism and achievements of our colleagues making outstanding accomplishments in their respective practice settings.  However, often I think we overlook a special niche for pharmacists, members of both the pharmacy community and the armed forces who sacrifice much more than many and play a critical role on the forefront of disaster relief and medical relief programs yet often do not receive the recognition they deserve.

Thus, it is my pleasure and privilege to depict pharmacists and technicians who work tirelessly in the armed forces of the United States and other nations while representing the core values of a pharmacist in their honesty, integrity, and accountability while delivering quality patient focused care with genuine leadership skills, professional ethics and morals, cultural competency, and substantive commitment to the social needs of the communities they serve.  The following pictures are from the Joint Task Force based in Bravo Soto Cano Airbase in Honduras; the Australian Defense Force medical team who participated in Operation Pakistan Assist; volunteer pharmacists who served with Medical Wings International in Haiti relief programs; and The Mission Transition Task Force Health Services Unit of the Canadian Army.  These pictures truly expose us to a unique path in pharmacy where few dare to tread but the rewards and potential to change lives are indescribable.

eMAR

Recent Posts

Oxidative Stress and Its Impact on Vitiligo

By: Zurriya Faran, PharmD Candidate c/o 2031 The visible loss of skin pigmentation often indicates…

2 months ago

Thiamine Metabolic Dysfunction Syndrome: Overview, importance, MOA, and treatment

By: Archana Murugan, PharmD candidate c/o 2029 Overview             Thiamine metabolic dysfunction syndrome (TMDS) refers…

2 months ago

Updated Guidelines for the Treatment of Multidrug and Rifampin-Resistant TB and Promising New Anti-TB Drugs in Phase 2/3 Trials

By: Kevin Lee, PharmD Candidate c/o 2028, Angela Yin, PharmD Candidate c/o 2028             The…

2 months ago

Sixth Year Perspective: Interview with Ariella Zadrima, PharmD Candidate, c/o 2026

By: Aymon Choudhury, PharmD Candidate c/o 2027 APPE questions: How did your APPE rotations shape…

2 months ago

Foundayo: The New Drug in the GLP-1 market

By: Sariah Grant, PharmD Candidate c/o 2027             The rise of glucagon-like peptide -1 receptor…

2 months ago

Should All Drugs be OTC? Risks and Consequences of the FDA Commissioner Statement

By: Amanda Kastel, PharmD Candidate c/o 2027 In February 2026, FDA Commissioner Marty Makary stated…

2 months ago